ALFUZOSIN Drug Patent Profile
✉ Email this page to a colleague
When do Alfuzosin patents expire, and when can generic versions of Alfuzosin launch?
Alfuzosin is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Pharmobedient, Sun Pharm, Torrent Pharms, Unichem, and Wockhardt Bio Ag. and is included in nine NDAs.
The generic ingredient in ALFUZOSIN is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alfuzosin
A generic version of ALFUZOSIN was approved as alfuzosin hydrochloride by APOTEX INC on July 18th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALFUZOSIN?
- What are the global sales for ALFUZOSIN?
- What is Average Wholesale Price for ALFUZOSIN?
Summary for ALFUZOSIN
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Drug Prices: | Drug price information for ALFUZOSIN |
| DailyMed Link: | ALFUZOSIN at DailyMed |
US Patents and Regulatory Information for ALFUZOSIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | ALFUZOSIN HYDROCHLORIDE | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079013-001 | Jul 18, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Torrent Pharms | ALFUZOSIN HYDROCHLORIDE | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079054-001 | Jul 18, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Invagen Pharms | ALFUZOSIN HYDROCHLORIDE | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 090284-001 | Jan 17, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
